{"id":"NCT01596335","sponsor":"Mitsubishi Tanabe Pharma Corporation","briefTitle":"Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease","officialTitle":"To Evaluate the Efficacy and Safety of TA-650 in Comparison With a Control Drug Polyethylene Glycol-treated Human Immunoglobulin (VGIH) in Patients With Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin (IVIG).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05","primaryCompletion":"2014-10","completion":"2014-10","firstPosted":"2012-05-11","resultsPosted":"2018-09-26","lastUpdate":"2018-10-25"},"enrollment":31,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin"],"interventions":[{"type":"DRUG","name":"TA-650","otherNames":[]},{"type":"DRUG","name":"Polyethylene Glycol-treated Human Immunoglobulin (VGIH)","otherNames":[]}],"arms":[{"label":"TA-650","type":"EXPERIMENTAL"},{"label":"VGIH","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of TA-650 in comparison with a control drug Polyethylene Glycol-treated Human Immunoglobulin (VGIH) in patients with Kawasaki disease refractory to initial therapy with Intravenous Immunoglobulin (IVIG). The pharmacokinetics of TA-650 is also examined.","primaryOutcome":{"measure":"Defervescence Rate Within 48 Hours After the Start of the Study Drug Administration","timeFrame":"Up to 48hours","effectByArm":[{"arm":"TA-650","deltaMin":75,"sd":null},{"arm":"Polyethylene Glycol-treated Human Immunoglobulin (VGIH)","deltaMin":33.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":8,"countries":["Japan"]},"refs":{"pmids":["29386515"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":16},"commonTop":["Double stranded DNA antibody positive","Epistaxis","Nasopharyngitis","Upper respiratory tract inflammation","Constipation"]}}